乌拉地尔与硝普钠对高血压脑出血早期活动性出血的效果

doi:10.3969/j.issn.1006-6233.2018.02.041

Abstract
Figure/Table
References
Related Citation (6)

Download: PDF (1314 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To investigate and compare the effect of urapidil and sodium nitroprusside on early active bleeding after hypertensive intracerebral hemorrhage. Methods: 120 patients with hypertensive intracerebral hemorrhage admitted from January 2015 to June 2017 were randomly divided into two groups: urapidil and uracil sodium, sodium nitroprusside and sodium nitroprusside respectively Group hematoma volume, neurological score, disease-related parameters, long-term prognosis and adverse reactions. Results: The hematoma volume of the patients in the urapidil group was significantly lower than those in the sodium nitroprusside group at 1 week, 2 weeks and 4 weeks after treatment, and CSS scores were significantly higher than those in the sodium nitroprusside group. After treatment, the systolic blood pressure Viscosity, low cut-off viscosity, plasma viscosity, erythrocyte sedimentation rate and hematocrit were significantly lower than those in sodium nitroprusside group. MMSE score and FMA score were significantly higher than those in the three months after treatment There was a significant difference between sodium nitroprusside group and sodium nitroprusside group (P <0.05). There was no significant difference in ADR between the two groups during treatment (P> 0.05). Conclusion: Compared with sodium nitroprusside, urapidil has a more significant effect on early active bleeding in patients with hypertensive intracerebral hemorrhage.

Key words： Urapidil Sodium nitroprusside Hypertensive intracerebral hemorrhage Early active bleeding

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Ruilian
	CHEN Xindong
	HUANG Yanzhen

Cite this article:

CHEN Ruilian,CHEN Xindong,HUANG Yanzhen. Effect of Urapidil and Sodium Nitroprusside on Early Active Bleeding in Hypertensive Intracerebral Hemorrhage[J]. HeBei Med, 2018, 24(2): 332-336.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2018.02.041 OR http://www.hbyxzzs.cn/EN/Y2018/V24/I2/332

[1] 赵淑艳.早期治疗对于高血压脑出血患者疗效的影响[J].吉林医学,2012,33(33):7194.
[2] 苏民,黄冠宇,武登峰,等.早期控制性降压对高血压脑出血患者血肿再扩大的影响[J].中国实用医刊,2014,41(6):25~26.
[3] 李玲,张锦丽,王璐琰.早期降压对高血压性脑出血患者近期预后影响[J].中国医刊,2010,45(7):53~54.
[4] Inamasu J, Moriya S, Oheda M,et al. Role of catecholamines in acute hypertensive response: subarachnoid hemorrhage versus spontaneous intracerebral hemorrhage[J]. Blood Press Monit, 2015,20(3):132~137.
[5] 李玲,张锦丽,宋扬.早期降压对高血压性脑出血患者近期疗效影响[J].现代中西医结合杂志,2011,20(22):2787~2788.
[6] 朱路明,王开欣,杨冰.乌拉地尔治疗高血压脑出血对患者血肿大小的影响[J].中国实用神经疾病杂志,2016,19(18):112~114.
[7] Yang LJ, Cui JL, Wu TM,et al. Sequential therapy for non-thalamus supratentorial hypertensive intracerebral hemorrhages[J].Eur Rev Med Pharmacol Sci,2014;18(23):3653~3658.
[8] 陈梅霞.乌拉地尔与硝普钠治疗高血压脑出血的疗效对比[J].海峡药学,2014,26(12):175~176.
[9] 杨志雄,余冬平,杨仕光.尼卡地平和乌拉地尔对高血压脑出血术后的疗效比较[J].中国实用神经疾病杂志,2010,13(5):6~8.
[10] 冯卫东,梁景利,吕云峰,等.降压药物对高血压性脑出血患者围术期血流动力学的影响[J].中国医药导报,2012,9(26):71~72.
[11] Gu B, Zhao YC, Yang ZW,et al. HindIII polymorphism in the lipoprotein lipase gene and hypertensive intracerebral hemorrhage in the Chinese Han population[J].Stroke Cerebrovasc Dis,2014,23(6):1275~1281.
[12] 连晓东,林麒.高血压并发脑出血尼卡地平治疗期间血钙和血肌酐水平的变化及意义[J].广东医学,2016,37(17):2660~2663.
[13] 董景宣,周莉.不同降压药物对急性高血压性脑出血患者颅内血肿增大的预防作用[J].中国实用神经疾病杂志,2014,17(13):65~66.
[14] Gushcha AO, Semenov MS, Lepsveridze LT. Experience of endoscopic removal of hypertensive intracerebral hemorrhage. [J] Zh Vopr Neirokhir Im N N Burdenko,2015,79(6):71~76.
[15] 储俭兵,苑瑞敏,陈广生,等.不同降血压药物预防高血压脑出血后早期血肿扩大的研究[J].中华神经医学杂志,2013,12(3):278~281.
[16] 段慧,韩国辉,王秋娟.硝普钠联合乌拉地尔治疗脑出血急性期高血压的对照研究[J].中国实用神经疾病杂志,2014,17(12):19~21.
[17] 郭熙雄,王列,张美彪.硝普钠联合乌拉地尔治疗高血压脑出血的效果对比分析[J].海峡药学,2012,24(11):156~157.